(S (PP (IN For) (NP (QP (JJR more) (IN than) (DT a)) (NN decade))) (, ,) (NP (NP (NN doubt)) (PP (IN about) (NP (NNS vaccines)))) (VP (VBZ has) (VP (VBN become) (NP (DT an) (ADJP (RB increasingly) (JJ important)) (JJ global) (NN issue)))) (. .))
(S (NP (CD Two) (JJ major) (NNS asymmetries)) (VP (VBP appear)) (. .))
(S (NP (NN Vaccine) (NNS critics)) (VP (VBP concentrate) (NP (PRP$ their) (NNS posts)) (PP (IN on) (NP (NP (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (JJ controversial) (NNS vaccines) (CC and) (NNS adjuvants)))))) (. .))
(S (NP (DT This) (JJ double) (NN asymmetry)) (VP (MD can) (VP (VB have) (NP (JJ serious) (NNS consequences)))) (. .))
